"A head-to-head study comparing lithium and depakote for bipolar disorder"

Lithium or Divalproex (Depakote) for Bipolar Disorder?

The two mainstays of treatment for Bipolar Disorder underwent another head-to-head study, but this time in older patients.  This randomized, double-blind, study compared tolerability and efficacy in 224 inpatients and outpatients age 60 or older with bipolar I disorder who presented with manic, hypomanic, or mixed episode symptoms.  The authors hypothesized that patients would have a greater response and tolerability to Depakote.  However, after nine weeks, response rates did not differ significantly (79% for lithium and 73% for Depakote) with lithium achieving a greater reduction in manic symptoms.  Both medications were well tolerated with equal degrees of sedation with lithium tending to more frequently produce tremor.

View Source

About Telepsychiatry Associates!

TelePsychiatry Associates, LLC specialized in the remote delivery of psychiatric care to patients who cannot easily access care or who prefer the privacy and convenience of care provided using advanced technologies.  Our practitioners are skilled in the diagnosis and treatment of a wide variety of different conditions including: depression, bipolar affective disorder, alcohol use disorders, opiate dependence, substance detoxification, substance withdrawal management, anxiety disorders, post-traumatic stress disorder, trauma related to sexual or physical abuse, and weight loss management, among others.  

The types of treatments provided will depend upon your practitioner and the problems needing attention.  Whether in-office treatment or tele-health technology is employed depends on a number of factors including patient preferenence, location, and type and severity of the condition.  After a short consultation, we will be able to determine the best fit for you and your provider.  

Ⓒ 2020 Telepsychiatry Associates
Privacy Policy & Disclaimer